EGFR and glioblastoma: However, some studies solved the delivery issue of this agent using direct intracranial infusion; the cetuximab successfully blocked glioblastoma cell invasion in a xenograft model, although this was found only in cells with high expression of EGFR and its variant EGFRvIII [65].